Literature DB >> 15015964

Treatment advances in multiple myeloma.

Guido Tricot1, Bart Barlogie, Frits Van Rhee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15015964     DOI： 10.1111/j.1365-2141.2004.04851.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  MiR-144-3p inhibits cell proliferation and induces apoptosis in multiple myeloma by targeting c-Met.

Authors:  Yue Zhao; Zhongshi Xie; Jie Lin; Peng Liu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  CD28-mediated regulation of multiple myeloma cell proliferation and survival.

Authors:  Nizar J Bahlis; Anne M King; Despina Kolonias; Louise M Carlson; Hong Yu Liu; Mohamad A Hussein; Howard R Terebelo; Gerald E Byrne; Bruce L Levine; Lawrence H Boise; Kelvin P Lee
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

3.  Preoperative elevation of serum C--reactive protein is predictive for prognosis in myeloma bone disease after surgery.

Authors:  A Zahlten-Hinguranage; H Goldschmidt; F W Cremer; G Egerer; T Moehler; D Witte; L Bernd; D Sabo; F Zeifang
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.